Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Amarin Corporation plc
AMRN | US
0.57
USD-0.01
-0.88%
AMRN | US
About Amarin Corporation plc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
0.57
Open
0.59
High
0.59
Low
0.57
Amarin Corporation plc a pharmaceutical company engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States European countries Canada Lebanon and the United Arab Emirates. It offers VASCEPA a prescription-only omega-3 fatty acid product used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co. Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin Ireland.
View LessAMRN | US
Risk
40.0
Sharpe
-0.40
Luna's Score
37/100
Recommendation
Sell
Luna says (AMRN | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
35.8%1 month
40.0%3 months
51.5%6 months
70.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
500.00
Price to book
0.42
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-5.80
Ent. to rev.
0.08
PEG
-1.74
Other Fundamentals
EBITDA
-23.79M
MarketCap
236.42M
MarketCap(USD)
236.42M
Div. yield
-
Op. margin
-0.78
Erngs. growth
-94.20
Rev. growth
-15.80
Ret. on equity
-5.98
Short ratio
26.50
Short perc.
4.40
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.05
Range1M
0.09
Range3M
0.25
Volumes: Market Activity
Rel. volume
0.66
Price X volume
282.44K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.80 | - | Cheaper |
| Ent. to Revenue | 0.08 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.42 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 51.51 | - | Lower Risk |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 236.42M | - | Emerging |
